CogniCare

CogniCare, designed for the neurodevelopmental, neurobehavioral and neuropsychiatric population, utilizes L-Carnosine as its key ingredient. This dipeptide breaks down into L-Histidine and β-Alanine, promoting both proper neuro signalling and improved synaptic plasticity.

Clinical trials in India have shown promising results, suggesting significant improvement in behaviour and cognition for people using CogniCare.